menu search

CNMD / ConMed: Still Fairly Priced, Turning More Constructive

ConMed: Still Fairly Priced, Turning More Constructive
CONMED Corporation had a reasonable growth quarter with upsides in key markets. Orthopedics is certainly an exciting growth area and offers leverage with each additional gain in market share. Read More
Posted: Dec 9 2022, 18:16
Author Name: Seeking Alpha
Views: 110774

CNMD News  

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

By Seeking Alpha
October 28, 2023

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Conmed posted another strong quarter, with low double-digit growth and operating margin leverage, as AirSeal and Buffalo Filter continue to grow well more_horizontal

Conmed (CNMD) Reports Q3 Earnings: What Key Metrics Have to Say

By Zacks Investment Research
October 25, 2023

Conmed (CNMD) Reports Q3 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended September 2023, it could be w more_horizontal

CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 25, 2023

CONMED Corporation (CNMD) Q3 2023 Earnings Call Transcript

CONMED Corporation (NYSE:CNMD ) Q3 2023 Earnings Conference Call October 25, 2023 4:30 PM ET Company Participants Curt Hartman – President and Chief more_horizontal

Conmed (CNMD) Q3 Earnings and Revenues Surpass Estimates

By Zacks Investment Research
October 25, 2023

Conmed (CNMD) Q3 Earnings and Revenues Surpass Estimates

Conmed (CNMD) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings more_horizontal

Here's Why You Should Retain CONMED (CNMD) Stock for Now

By Zacks Investment Research
September 25, 2023

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum. more_horizontal

Here's Why You Should Retain CONMED (CNMD) Stock for Now

By Zacks Investment Research
August 24, 2023

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum. more_horizontal

CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript

By Seeking Alpha
July 26, 2023

CONMED Corporation (CNMD) Q2 2023 Earnings Call Transcript

CONMED Corporation (NYSE:CNMD ) Q2 2023 Earnings Conference Call July 26, 2023 4:30 PM ET Company Participants Curt Hartman - Chairman, President, and more_horizontal

Conmed (CNMD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
July 26, 2023

Conmed (CNMD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare more_horizontal


Search within

Pages Search Results: